RxDoctor Payments Data

Matthew Goldman, MD

Vascular Surgery · Winston Salem, NCNPI 1992947808

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,900 of the $11,405 with a category attached, or 69.3%. 9 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 57.1% of the total. Reporting peaked in 2020 at $5,535 and has fallen 90.0% since, to $552 in 2025.

$11,405in general payments, 2019–2025

Across 37 payments — averaging $308.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$7K
  • Silk Road Medical, Inc.$4K
  • Cook Medical LLC$226
  • Boston Scientific$170
  • Shape Memory Medical Inc.$144
  • Acera Surgical, Inc.$125
  • plus $141 from 3 others

What the payments were for

  • Consulting fees$7,90069%
  • Travel & lodging$9538%
  • Food & beverage$2,53322%
  • Education$180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,405 in reported general payments places this provider in the 75th percentile of 119 vascular surgery providers in North Carolina.

See all vascular surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$105,017
Medicare patients
534
Services billed
742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$11,991
Cilostazol58$1,273
Atorvastatin Calcium44$488
ClopidogrelClopidogrel Bisulfate63$466
Rosuvastatin Calcium21$435

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →